ECR_2016

Building on its 100+ years of experience, Agfa HealthCare develops innovations that offer the ease of use customers need to maximize the potential of their solutions, with designs that keep the user and customer in mind. With its strategy of one platform for IT and one platform for imaging, the company is doing exactly that: simplifying even while enhancing performance. Visit us @ECR 2016, Expo A, booth #103 Find out more, visit agfahealthcare.com VIsuAlIzIng THE FuTuRE oF HEAlTHCARE M 1013_ Agfa ad Visualizing.indd 1 15/02/16 13:57 www.healthcare-in-europe.com 7 EH @ ECR learning tools increasingly let the sys- tems learn step by step how to read and interpret the images, but this requires that image data are prepared sufficiently and are made comparable and analysable by computers. Finally, in biobanking image bio- markers can be related to data in the other -omics domains. However, these tools are not available as yet in the clinical setting. Closing the gap ‘Currently we have a mismatch that must be solved,’ he states, specifying his demand: ‘We should try to close the gap between the research infra- structure and the PACS system. In other words, using the tools that are available in a PACS in a research envi- ronment and using the PACS for more advanced research analysis would be the optimum. Combining the advan- tages of both approaches would be the best solution.’ This includes a strat- egy of storage of anonymised data in a split PACS system. One for clinical use and one for research use with a separate access to the two domains, and implementation of automated algorithms that can make use of mul- tiple image datasets that, for example, can detect lesions and automatically measures their size. ‘There have to be advanced algorithms that can ana- lyse large scale data and export the quantitative imaging biomarkers to one’s research database,’ Van der Lugt believes. ‘This approach allows the use of the data richness of the images that are available for most of the patients included in biobanks. n devices wide imaging area. In addition, the advanced ‘SUREengine’ (Shimadzu Ultimate Real-time Enhancement Engine) technology supports excel- lent image quality. It optimises the entire image for a more detailed rendering of all areas examined, including smaller and otherwise faint target objects.’ Further details: www.shimadzu-medical.eu Peter Wochnik (right) from Shimadzu introduces the new generation of X-ray and fluoroscopy systems Sonialvision G4 to Asklepios-Klinik Chief Executive Johann Bachmeyer (left) and District Administrator Elmar Stegmann (centre). Total brain volume of an individual patient can be related to a reference based on the analysis of multiple patients. The brain in the lower panel has a volume that is below the 5th percentile of the population at the same age. At ECR 2016 Shimadzu Europa GmbH Expo X2. Stand 325 ECR 2016 Thursday 4 March 8:30–10:00 a.m. Studio 2016 Biobanks meet imaging Copyright: asharkyu/shutterstock.com M 1013_ Agfa ad Visualizing.indd 115/02/1613:57

Pages Overview